Rallybio Corp.
Key Metrics
Market Snapshot
About
Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating development of life-transforming therapies for patients with severe and rare diseases. The company focuses on inhibiting harmful immune responses underlying disease, replacing missing or deficient enzymes or proteins, and modulating dysregulated immune responses. Rallybio has a pipeline of product candidates addressing complement-mediated diseases and genetic disorders.